|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||||||
| Investments at fair value: | |||||||||||||||||
| Investments at fair value: | |||||||||||||||||
| Companies less than 5% owned | |||||||||||||||||
| Companies 5% to 25% owned | |||||||||||||||||
| Companies more than 25% owned | |||||||||||||||||
| Total investments at fair value: | |||||||||||||||||
| Cash | |||||||||||||||||
| Cash equivalents (cost: $388,944 and $348,585, respectively) | |||||||||||||||||
| Dividends receivable | |||||||||||||||||
| Interest receivable | |||||||||||||||||
| Receivable for investments sold | |||||||||||||||||
| Prepaid expenses and other assets | |||||||||||||||||
| Total assets | |||||||||||||||||
| Liabilities | |||||||||||||||||
| Debt ($1,145,443 and $1,154,436 face amounts, respectively, reported net of unamortized debt issuance costs of $7,236 and $8,082, respectively. See note 7) | |||||||||||||||||
| Payable for investments and cash equivalents purchased | |||||||||||||||||
| Distributions payable | |||||||||||||||||
| Management fee payable (see note 3) | |||||||||||||||||
| Performance-based incentive fee payable (see note 3) | |||||||||||||||||
| Interest payable (see note 7) | |||||||||||||||||
| Administrative services payable (see note 3) | |||||||||||||||||
| Other liabilities and accrued expenses | |||||||||||||||||
| Total liabilities | |||||||||||||||||
| Net Assets | |||||||||||||||||
| Common stock, par value $0.01 per share, 200,000,000 and 200,000,000 common shares authorized, respectively, and 54,554,634 and 54,554,634 shares issued and outstanding, respectively | |||||||||||||||||
| Paid-in capital in excess of par | |||||||||||||||||
| Accumulated distributable net loss | |||||||||||||||||
| Total net assets | |||||||||||||||||
| Net Asset Value Per Share |
Loading...
